SentinelOne adds Claude Mythos 5.1 to AI cybersecurity service as $1.22bn recurring revenue supports expansion
Read More Healthcare Industry News FDA grants breakthrough device designation to Acrivon’s OncoSignature assay for endometrial cancer Acrivon Therapeutics has secured a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its… byPallavi MadhirajuFebruary 5, 2025